Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease

Journal of Cardiology

Volumn 62, Issue 6, 2013, Pages 343-347

  Kaya, Hasan ^a   Ertaş, Faruk ^a   Oylumlu, Mustafa ^a   Bilik, Mehmet Zihni ^a   Yildiz, Abdulkadir ^a   Yüksel, Murat ^a   Polat, Nihat ^a   Acet, Halit ^a   Işik, Ferhat ^a   Ülgen, Mehmet Siddik ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Epicardial fat thickness; Flow mediated vasodilation

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EPICARDIUM; FEMALE; HEART EJECTION FRACTION; HUMAN; MALE; MIDDLE AGED; STABLE ANGINA PECTORIS; THICKNESS; VASODILATATION;

CORONARY ARTERY DISEASE; EPICARDIAL FAT THICKNESS; FLOW-MEDIATED VASODILATION;

ADIPOSE TISSUE; AGED; ANGINA, STABLE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; VASODILATION;

EID: 84892446122     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.05.009     Document Type: Article

References (42)

1. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov-Blat L., O'Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
2. Rosito G.A., Massaro J.M., Hoffmann U., Ruberg F.L., Mahabadi A.A., Vasan R.S., O'Donnell C.J., Fox C.S. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008, 117:605-613.
3. Zhang L., Zalewski A., Liu Y., Mazurek T., Cowan S., Martin J.L., Hofmann S.M., Vlassara H., Shi Y. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003, 108:472-478.
4. Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., Keaney J.F., Meigs J.B., Lipinska I., Kathiresan S., Murabito J.M., O'Donnell C.J., Benjamin E.J., Fox C.S. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007, 116:1234-1241.
5. Keophiphath M., Achard V., Henegar C., Rouault C., Clement K., Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 2009, 23:11-24.
6. Sironi A.M., Pingitore A., Ghione S., De Marchi D., Scattini B., Positano V., Muscelli E., Ciociaro D., Lombardi M., Ferrannini E., Gastaldelli A. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008, 51:282-288.
7. Teijeira-Fernandez E., Eiras S., Grigorian-Shamagian L., Fernandez A., Adrio B., Gonzalez-Juanatey J.R. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 2008, 22:856-863.
8. Ertas F., Kaya H., Acet H., Cil H., Akyüz A., Islamoǧlu Y., Tekbaş E., Aritürk Z., Aydin M., Soydinç S. Increased echocardiographic epicardial fat thickness is related to impaired diurnal blood pressure profiles. Blood Press 2012, 21:202-208.
9. Nelson M.R., Mookadam F., Thota V., Emani U., Al Harthi M., Lester S.J., Cha S., Stepanek J., Hurst R.T. Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?. J Am Soc Echocardiogr 2011, 24:339-345.
10. Tok D., Kadife I., Turak O., Ozcan F., Başar N., Caǧli K., Aras D., Topaloǧlu S., Aydoǧdu S. Increased epicardial fat thickness is associated with low grade systemic inflammation in metabolic syndrome. Turk Kardiyol Dern Ars 2012, 40:690-695.
11. Lahera V., Goicoechea M., de Vinuesa S.G., Miana M., De Las Heras N., Cachofeiro V., Luño J. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 2007, 14:243-248.
12. Ercan E., Tengiz I., Duman C., Nalbantgil I. Investigation of flow-mediated dilation response in normal coronary angiographic patients. Angiology 2005, 56:671-675.
13. Maldonado F.J., Miralles Jde H., Aguilar E.M., Gonzalez A.F., García J.R., García F.A. Relationship between noninvasively measured endothelial function and peripheral arterial disease. Angiology 2009, 60:725-731.
14. Bots M.L., Westerink J., Rabelink T.J., de Koning E.J. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005, 26:363-368.
15. Peretz A., Leotta D.F., Sullivan J.H., Trenga C.A., Sands F.N., Aulet M.R., Paun M., Gill E.A., Kaufman J.D. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord 2007, 7:11.
16. Ryan T.J., Faxon D.P., Gunnar R.M., Kennedy J.W., King S.B., Loop F.D., Peterson K.L., Reeves T.J., Williams D.O., Winters W.L. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988, 78:486-502.
17. Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alessi G., Di Mario U., Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
18. Silaghi A.C., Poant L., Valea A., Pais R., Silaghi H. Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction?. Med Ultrason 2011, 13:15-20.
19. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., Di Mario U., Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88:5163-5168.
20. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., Vallance P., Vita J., Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the international brachial artery reactivity task force. JACC 2002, 39:257-265. International Brachial Artery Reactivity Task Force.
21. Roman M.J., Naqvi T.Z., Gardin J.M., Gerhard-Herman M., Jaff M., Mohler E. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006, 19:943-954.
22. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543.
23. Iacobellis G., Pond C.M., Sharma A.M. Different "weight" of cardiac and general adiposity in predicting left ventricle morphology. Obesity (Silver Spring) 2006, 14:1679-1684.
24. Iacobellis G., Sharma A.M. Adiposity of the heart. Ann Intern Med 2006, 145:554-555.
25. Cetin M., Kocaman S.A., Durakoǧlugil M.E., Erdoǧan T., Ergül E., Dogan S., Canga A. Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function. J Cardiol 2013, 10.1016/j.jjcc.2012.12.015.
26. Shemirani H., Khoshavi M. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease - an observational study. Anadolu Kardiyol Derg 2012, 12:200-205.
27. Ahn S.G., Lim H.S., Joe D.Y., Kang S.J., Choi B.J., Choi S.Y., Yoon M.H., Hwang G.S., Tahk S.J., Shin J.H. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008, 94:e7.
28. Comert N., Yucel O., Ege M.R., Yaylak B., Erdogan G., Yilmaz M.B. Echocardiographic epicardial adipose tissue predicts subclinical atherosclerosis: epicardial adipose tissue and atherosclerosis. Angiology 2012, 63:586-590.
29. Park E.M., Choi J.H., Shin I.S., Yun K.H., Yoo N.J., Oh S.K., Kim N.H., Jeong J.W. Echocardiographic epicardial fat thickness on short term prognosis in patients with acute coronary syndrome. J Cardiovasc Ultrasound 2008, 16:42-47.
30. Iacobellis G., Pellicelli A.M., Sharma A.M., Grisorio B., Barbarini G., Barbaro G. Relation of subepicardial adipose tissue to carotid intima media thickness in patients with human immunodeficiency virus. Am J Cardiol 2007, 99:1470-1472.
31. Jeong J.W., Jeong M.H., Yun K.H., Oh S.K., Park E.M., Kim Y.K., Rhee S.J., Lee E.M., Lee J., Yoo N.J., Kim N.H., Park J.C. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007, 71:536-539.
32. Lüscher T.F., Barton M. Biology of the endothelium. Clin Cardiol 1997, 20:II3-II10.
33. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:III27-III32.
34. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
35. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
36. Diodati J.G., Dakak N., Gilligan D.M., Quyyumi A.A. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation 1998, 98:17-24.
37. Brevetti G., Silvestro A., Schiano V., Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003, 108:2093-2098.
38. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
39. Hamasaki S., Tei C. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2011, 57:231-238.
40. Mazzoccoli G., Dagostino M.P., Fontana A., Copetti M., Pellegrini F., Grilli M., Greco A. Concomitant evaluation of flow-mediated vasodilation and epicardial fat thickness in idiopathic deep venous thrombosis. J Biol Regul Homeost Agents 2012, 26:81-88.
41. Laine P., Kaartinen M., Penttilä A., Panula P., Paavonen T., Kovanen P.T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999, 99:361-369.
42. Baker A.R., Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., Kumar S., McTernan P.G. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1.